Company: CWAN
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001628280-25-008298
Chunk: 4

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 Financial Statements and Exhibits.

(d): The following exhibits are being filed herewith:

  Exhibit Number      Description                                                                                                                                                                               
            99.1      Press release entitled " Clearwater A nalytics and Enfusion Annou n ce Expiration of Hart-Scott-Rodino Act Waiting Period For Proposed Acquisition of Enfusion " dated February 26, 2025  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
             104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                                               

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                             Clearwater Analytics Holdings, Inc.  
  Date:      February 26, 2025      By:      /s/ Jim Cox                          
                                             Jim Cox, Chief Financial Officer